Survival benefit of nephroureterectomy in systemic therapy exposed metastatic upper tract urinary urothelial carcinoma patients.
Morra S, Incesu RB, Scheipner L, Baudo A, Jannello LMI, Siech C, de Angelis M, Tian Z, Creta M, Califano G, Collà Ruvolo C, Saad F, Shariat SF, Chun FKH, de Cobelli O, Musi G, Briganti A, Tilki D, Ahyai S, Carmignani L, Longo N, Karakiewicz PI.
Morra S, et al. Among authors: chun fkh.
World J Urol. 2024 May 22;42(1):343. doi: 10.1007/s00345-024-05057-3.
World J Urol. 2024.
PMID: 38775841